International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-1 doi: 10.5281/zenodo.12787897
Original Research Article
Prevalence and Risk Factors of Dry Eye Syndrome Among Urban Office Workers Using Digital Screens
Published
Jan. 19, 2025
Abstract

Background: Digital screen use has become ubiquitous in modern workplaces, potentially increasing the risk of dry eye syndrome (DES).Objective: To determine the prevalence of DES among urban office workers and identify associated risk factors, particularly focusing on screen time and workplace environmental conditions.Methods: A cross-sectional study was conducted among 460 office workers using digital screens. Participants underwent comprehensive ophthalmic examination including tear break-up time (TBUT) and Schirmer's test. Environmental factors were measured, and symptoms were assessed using the Ocular Surface Disease Index (OSDI).Results: The prevalence of DES was 53.9% (95% CI: 49.3-58.5%). Mean daily screen time was 8.5 ± 1.7 hours. DES prevalence increased significantly with screen time (p<0.001), from 39.1% in those using screens 6-7 hours to 69.4% in those exceeding 9 hours daily. Multivariate analysis identified significant risk factors including female gender (OR=1.6, p=0.002), low humidity (OR=2.1, p<0.001), and close screen distance (OR=1.7, p=0.012).Conclusion: DES is highly prevalent among urban office workers, with screen time duration and workplace environmental factors serving as significant modifiable risk factors. Implementation of workplace environmental modifications and screen time management strategies may help reduce DES prevalence.

Recommended Articles
Loading Image...
Volume-6, Issue-1
Citations
1786 Views
15 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved